Articles


Ocugen

Ocugen’s OCU400 Earns FDA’s RMAT Designation, Enhancing Prospects for Retinitis Pigmentosa Treatment

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a Pennsylvania-based biopharmaceutical company, has scored a significant regulatory milestone this week with the U.S. Food and Drug Administration (FDA) granting Regenerative Medicine …

Ocugen’s OCU400 Earns FDA’s RMAT Designation, Enhancing Prospects for Retinitis Pigmentosa Treatment Read More



US Capitol

Rep. Houlahan Celebrates Passage of Defense Bill Strengthening National Security and Supporting Military Personnel

Representative Chrissy Houlahan (D-PA) has lauded the signing into law of the FY24 National Defense Authorization Act (NDAA), a bipartisan, bicameral bill that includes dozens of her legislative contributions aimed …

Rep. Houlahan Celebrates Passage of Defense Bill Strengthening National Security and Supporting Military Personnel Read More